.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Nyce is stocked at 189 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Staten Island, and Buffalo. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Nyce concentrated revenue around Concentrates at 57.38% share with year-over-year growth of 81.54% and month-over-month growth of 6.39%, while Vapor Pens held 21.93% share with 36.41% YoY and 5.40% MoM. Edible expanded YoY by 178.46% to 20.69% share but contracted MoM by 9.55%, contrasting with the brand-level YoY sales lift of 81.44% and a 14.25% YoY decline in average price to $38.44. The mix implies demand is tilting toward higher-potency formats even as price compression widens the audience, with Edible acting as a volatile growth leg that lifted annual gains but tempered monthly momentum.
Positioning-wise, a 5th rank in New York Concentrates alongside a 57.38% mix share and 6.39% MoM growth signals traction in a potency-led core, while the 36.41% YoY in Vapor Pens and 5.40% MoM add breadth without diluting the core identity. The 178.46% YoY Edible surge paired with a 9.55% MoM pullback suggests episodic trial rather than durable repeat, implying Nyce’s defensible stance is premium Concentrates halo with Vapor Pens as an adjacent on-ramp and Edible as an opportunistic, promotion-sensitive spike that requires retention tactics.
Competitive Landscape
Nyce sits at rank #5 in NY Concentrates in August 2026, improving 3 positions from #8 year over year, while holding steady versus May 2026–July 2026 at #5 and trailing its peak of #4 from February 2026; in contrast, UMAMII vaulted from #33 to #3 on a 3,294.5% year-over-year sales increase and Mfny (Marijuana Farms New York) remained #1 with 42.4% year-over-year growth, indicating Nyce’s rank gains are moderate relative to rivals’ faster ascent. With RYTHM holding #4 alongside 48.7% year-over-year growth and Jetpacks steady at #2 with 13.1% year-over-year growth, Nyce’s flat three-month rank and only one-rank gap from its February 2026 peak suggest a stabilization phase where maintaining share requires either a step-up in velocity or mix shifts to counter accelerating competitors.
Notable Products
Grape Solventless Hash Rosin Gummies 10-Pack (100mg) posted the steepest movement in August 2026 with a -29.5% MoM drop to rank 8, while Peach Live Hash Rosin Gummies 10-Pack (100mg) rose 43.4% MoM to hold rank 1, signaling volatility within the same format. Mixed Berry Live Hash Rosin Gummies 10-Pack (100mg) advanced 15.8% MoM at rank 3, and four of the top ten are Edible SKUs, indicating that gummies anchor the leaderboard even as some flavors diverge.
Within Concentrates, GMO x Oreoz Cold Cure Live Hash Rosin (1g) jumped 29.6% MoM at rank 7 while Donny Burger Cold Cure Solventless Live Hash Rosin (1g) slipped 6.8% MoM at rank 6, suggesting share is rotating between strains rather than expanding the category base. With Edibles occupying ranks 1–3 and Concentrates clustered from ranks 4–7 and 10, the mix points to Nyce leaning into gummies for velocity while treating strain variety in 1g rosin as a retention play rather than a growth engine.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
